Letter by Kohsaka et al Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial".

Shun Kohsaka, Shiori Nishimura, Hiraku Kumamaru

Journal: Circulation 2024;150(2):e28-e29

PMID: 38976603

Abstract

Address: Department of Cardiology, Keio University School of Medicine, Tokyo, Japan (S.K.).; Shizuoka Graduate University of Public Health, Japan (S.K., S.N., H.K.).; Department of Healthcare Quality Assessment, University of Tokyo Graduate School of Medicine, Japan (S.K., S.N., H.K.).; Shizuoka Graduate University of Public Health, Japan (S.K., S.N., H.K.).; Department of Healthcare Quality Assessment, University of Tokyo Graduate School of Medicine, Japan (S.K., S.N., H.K.).

DOI: 10.1161/CIRCULATIONAHA.124.069363

Link outs

Free resources

Medical:

https://medlineplus.gov/bloodthinners.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Atrial Fibrillation, Anticoagulants, Vitamin K, Frail Elderly, Administration, Oral, Aged, Randomized Controlled Trials as Topic, Drug Substitution